
(B) Epidural or spinal hematomas may occur in patients treated with ELIQUIS who are receiving neuraxial anesthesia or undergoing spinal puncture. If anticoagulation with ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant. (A) Premature discontinuation of any oral anticoagulant, including ELIQUIS ® (apixaban), increases the risk of thrombotic events. WARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA SELECTED IMPORTANT SAFETY INFORMATION IMPORTANT SAFETY INFORMATION MORE IMPORTANT SAFETY INFORMATION
#Pca aliquis trial#
The ELIQUIS Free 30-Day Trial offer is not health insurance.This Free 30-Day Trial card may not be sold, purchased, traded, or counterfeited.


By redeeming this offer, you certify that you have not previously filled a prescription for ELIQUIS.
#Pca aliquis download#
For those customers using mail order or any non-participating retail pharmacy, please call 86 to request a patient rebate form, or go to to download a form. The Co-pay Card will be accepted only at participating pharmacies.

Territories this offer is void where restricted or prohibited by law. Only valid in the United States, Puerto Rico, or other select U.S.All Program payments are for the benefit of the patient only.Upon expiration, eligible patients may re-enroll in the Co-pay Card Program. Activation and first use of the Co-pay Card must take place by December 31, 2022. Your acceptance of this offer confirms that this offer is consistent with your insurance and that you will report the value received as may be required by your insurance provider.Patients, pharmacists, and prescribers cannot seek reimbursement, from health insurance or any third party, for any part of the benefit received by the patient through this offer.Offer not applicable to co-pays of $10 or less.Eligible patients who present an activated Co-pay Card together with a valid prescription for ELIQUIS at participating pharmacies may pay as little as $10 per 30-day supply (up to 74 tablets for the first fill and up to 60 tablets for all subsequent fills) for up to 24 months, subject to a maximum annual benefit of $6400.
